SCHEMBL4764470

SCHEMBL4764470

CC(C)(C)OC(CC(=O)O)NC=O

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PGD P52209 1/20 0.35
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1204842 0.80 TSHR (0.35) TSHR
SCHEMBL28097907 0.77 PGD (0.36) PGDTSHR
SCHEMBL28114414 0.76 ADH1B (0.33)
SCHEMBL5622191 0.76 ADH1B (0.30)
SCHEMBL11081449 0.75 ADH1B (0.32)
SCHEMBL6292489 0.72 ADH1B (0.30)
SCHEMBL23510216 0.71 PPARA (0.43)
SCHEMBL7808944 0.70 MAPT (0.42) TSHR
SCHEMBL11378416 0.69 PGD (0.32) PGD
SCHEMBL7767539 0.69 ADH1B (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572678-A4 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARM INC (US) 2008-05-07 EP disclosed
EP-1572678-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS Elan Pharmaceuticals, Inc. (US) 2005-09-14 EP disclosed
WO-2004056319-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARMACEUTICALS INC. (US) 2004-07-08 WO disclosed
WO-2002062340-A1 HIGHLY LIPOPHILIC CAMPTOTHECIN PRODRUGS, METHODS OF PREPARATION, AND FORMULATIONS THEREOF UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2002-08-15 WO disclosed